Targeted proteomics for quantification of histone acetylation in Alzheimer's disease.
about
Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseasesEpigenetic Alterations in Alzheimer's DiseaseEpigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug ResponseDissecting Alzheimer disease in Down syndrome using mouse modelsConnecting the dots between tau dysfunction and neurodegenerationRecent advances in quantitative neuroproteomicsBiomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomicsSite-specific quantification of lysine acetylation in the N-terminal tail of histone H4 using a double-labelling, targeted UHPLC MS/MS approachQuantitative proteomic analysis of histone modificationsEpigenetic regulation of adult neural stem cells: implications for Alzheimer's disease.Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders.The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?Epigenomics of Alzheimer's disease.The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic ReviewQuantitative Proteomics of Sleep-Deprived Mouse Brains Reveals Global Changes in Mitochondrial Proteins.Dual Functional Small Molecule Probes as Fluorophore and Ligand for Misfolding ProteinsEpigenetic dysregulation of brainstem nuclei in the pathogenesis of Alzheimer's disease: looking in the correct place at the right time?Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats.Epigenetic determinants of healthy and diseased brain aging and cognition.Epigenetic studies in Alzheimer's disease: current findings, caveats, and considerations for future studies.Glia-based biomarkers and their functional role in the CNS.Folate and epigenetic mechanisms in neural tube development and defects.Environmental factors in the development and progression of late-onset Alzheimer's disease.Epigenetic drug discovery for Alzheimer's disease.The potential of epigenetic therapies in neurodegenerative diseasesQuantitation of protein post-translational modifications using isobaric tandem mass tags.Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?A new approach combining LC-MS and multivariate statistical analysis for revealing changes in histone modification levels.Quantitative proteomics reveals a role for epigenetic reprogramming during human monocyte differentiation.Global protein differential expression profiling of cerebrospinal fluid samples pooled from Chinese sporadic CJD and non-CJD patients.Neuron enriched nuclear proteome isolated from human brain.Proteomic Analysis of Endothelin-1 Targets in the Regulation of Cardiomyocyte Proliferation.Enhanced recovery of lyophilized peptides in shotgun proteomics by using an LC-ESI-MS compatible surfactant.Detection of Nuclear Protein Profile Changes by Human Metapneumovirus M2-2 Protein Using Quantitative Differential Proteomics.Systematic quantitative analysis of H2A and H2B variants by targeted proteomics.Epigenetic regulation of neuronal immediate early genes is associated with decline in their expression and memory consolidation in scopolamine-induced amnesic mice.Valproate improves memory deficits in an Alzheimer's disease mouse model: investigation of possible mechanisms of action.Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease.Alzheimer's Disease and Histone Code Alterations.
P2860
Q21284678-E0B93DBC-2AB6-4919-B511-A6A1555AFBE6Q26770475-98876BCB-73E5-42CB-90E5-D2ADBB48B770Q26772028-0F43F2A9-BC21-4424-90E2-DC5698539F4FQ26777254-201A4B29-F61D-4464-BA21-A84D1020B2D6Q26996848-5380B6B7-A7F8-4EBA-B8A7-662AD6731CFCQ27000073-67CE44C9-F228-4013-88CC-E8F5C172572FQ27024518-BC788B92-F21A-42C9-A7E9-F6F7F483F777Q28834522-E20F38B5-B369-4BA8-9ECA-907F49AF2474Q30375585-EE774C95-1E6F-446A-9971-FEB165B66D5BQ33841944-6D986186-3310-425F-A050-1B63C68BA6BAQ33858861-A158B049-80DC-4E5D-AC50-6B76C0957ECAQ34426210-D17E8680-44A4-418F-AB26-D0C001A45CC1Q34518584-F48A4381-B166-429E-80F9-0516279BD945Q36223734-BEE9C69E-4E43-4844-9CC9-ED19E1B1756FQ37296911-6F70400A-8423-4CBD-980D-D656DCB4368DQ37401787-1605BFBB-ED3E-4639-B507-FC0572A5ADF5Q37590630-0183F39E-8A7E-48F8-BC02-C338ECF92481Q37591215-BEDCE4BF-C7AF-462C-A1A1-E11C1A8858DDQ37598709-F15B1629-F3BC-4676-A936-AE6B50BBDC87Q37626479-A46F04D5-851B-49C0-B8FF-1B957898E063Q38081955-9AD50468-E725-4BD4-8E80-BFFC62C57802Q38135226-48EE3A58-AEF3-43D4-B301-14D5C1973DF1Q38199061-E436C25D-1371-410C-8366-DA6101143E42Q38225708-CC198C8A-C999-465B-9BDE-9851BE99C56EQ38234971-0B2956BF-D2EB-43DA-BBE0-1BE363581892Q38361906-D12EF015-0C43-4513-A5BF-9DCB81487DEEQ38583222-A1393290-FD14-4B95-A29C-C13B323256BFQ38592069-024D0012-D601-445B-B53D-E1CB6B0F298AQ38962129-392FBB69-BA6C-463B-A7C4-610B335DAD3EQ41700803-F8E1C7C9-1CFB-4A7F-B553-001631B73708Q42252580-E8C8842E-4EA7-481B-A728-355DACC2CC2FQ42539702-E5EACF19-CB6C-4A91-8F58-AC6960DC9D40Q46760103-04DAB2B1-3AFD-4DDD-AB1D-45CD5EB8070AQ46925961-3EF3016E-D794-4815-ACDF-3872701EC36BQ47160156-E9845CC0-5236-432A-B50B-453983F958ACQ48539829-152CE773-BDAE-460E-A60D-B93C6E6F9CDDQ48556387-D5B3EA4B-6AD0-473E-AFC4-C8B098F40B82Q48710262-ECA143C0-FCAC-4CEA-B7E0-51F020DB7E4DQ50420748-069A12DD-6548-4018-AFE2-8552CBA5715CQ50993017-EF193EC6-F5EF-46A1-ADB4-C1BFAA19CC67
P2860
Targeted proteomics for quantification of histone acetylation in Alzheimer's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Targeted proteomics for quantification of histone acetylation in Alzheimer's disease.
@en
Targeted proteomics for quantification of histone acetylation in Alzheimer's disease.
@nl
type
label
Targeted proteomics for quantification of histone acetylation in Alzheimer's disease.
@en
Targeted proteomics for quantification of histone acetylation in Alzheimer's disease.
@nl
prefLabel
Targeted proteomics for quantification of histone acetylation in Alzheimer's disease.
@en
Targeted proteomics for quantification of histone acetylation in Alzheimer's disease.
@nl
P2093
P2860
P356
P1433
P1476
Targeted proteomics for quantification of histone acetylation in Alzheimer's disease
@en
P2093
Andrew Crofton
Harry Vinters
Kangling Zhang
Matthew Schrag
Rishi Trivedi
Wolff Kirsch
P2860
P304
P356
10.1002/PMIC.201200010
P577
2012-04-01T00:00:00Z